Welcome to #1 DIGITAL HEALTH NEWS Portal

Philips, Emory Healthcare and Royal Perth Hospital in Australia Partner to Launch New Remote Intensive Care Monitoring Program

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and US-based Emory Healthcare have launched a new remote Intensive Care Unit (eICU) monitoring program, based at the Royal Perth Hospital in Western Australia, focused on improving the outcomes of high risk patients and advancing the globalization of critical care.

Read more ...

Computer-Designed Customized Regenerative Heart Valves

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing replacement parts in the laboratory, forms a key part of this research. The parts can be used to replace defective cells and tissues in the body and restore their normal functioning.

Read more ...

Applications for the G4A Global Accelerator Are Now Open

Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and enable positive disruption and progress within the digital health & care universe.

Read more ...

Philips Expands its Sleep & Respiratory Care Portfolio with the Acquisition of NightBalance

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands, that has developed an innovative, easy to use device to treat positional obstructive sleep apnea and positional snoring. Financial details of the transaction were not disclosed.

Read more ...

A New Way to Watch Brain Activity in Action

It's a neuroscientist's dream: being able to track the millions of interactions among brain cells in animals that move about freely, behaving as they would under natural circumstances. New technology developed at The Rockefeller University represents a big step toward realizing that goal.

Read more ...

Siemens Healthineers Fully on Track to Meet the Targets

Siemens Healthineers AG has posted good business figures in the first quarter following its successful initial public offering on March 16, 2018. Year-over-year revenue was up four percent at EUR 3.2 billion on a comparable basis. Despite continuing negative currency effects, the profit margin adjusted for non-recurring effects increased by 90 basis points to 17.4 percent, while adjusted profit was stable at EUR 560 million compared to the second quarter of 2017.

Read more ...

Gait Assessed with Body-Worn Sensors may Help Detect Onset of Alzheimer's Disease

Body-worn sensors used at home and in clinic by people with mild Alzheimer's to assess walking could offer a cost-effective way to detect early disease and monitor progression of the illness. A pilot study involving Newcastle University, UK, has revealed low-cost wearable devices could improve clinical trial efficiency and encourage research investment. Identification of clinical biomarkers, such as changes in walking characteristics and behaviours, are known to be important factors when looking at early warning signs of dementia.

Read more ...

R&D Digital Lead

As the R&D Digital Lead, you will be responsible for partnering across all GSK Consumer Health categories to develop a strategic pipeline of digital healthcare innovation. This will include pioneering new, creative approaches to develop intuitive digital diagnostics and therapeutics, as well as evaluating digital devices/sensors/apps either marketed or in various stages of development. You will be a key contributor to the R&D innovation strategy to deliver digital innovation including: devices, wearables, software, and apps.

Read more ...

Computers Equal Radiologists in Assessing Breast Density and Associated Breast Cancer Risk

Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic. Both assessment methods were equally accurate in predicting both the risk of cancer detected through mammography screening and the risk of interval invasive cancer - that is, cancer diagnosed within a year of a negative mammography result.

Read more ...

Consultation: Transformation Health and Care in the Digital Single Market

The present report provides an analysis of the results of consultation activities carried out by the European Commission in preparation of a Communication on the Transformation of Health and Care in the Digital Single Market. The main findings show that over 93% of over 1400 respondents to an online questionnaire believe that "Citizens should be able to manage their own health data". Furthermore, 83% of all respondents either agree or strongly agree with the statement that "Sharing of health data could be beneficial to improve treatment, diagnosis and prevention of diseases across the EU". The overwhelming majority of all respondents (73.6%) identify improved possibilities for medical research as a reason for supporting cross border transfer of medical data, which was higher than for their purpose of their own treatment (67.8%).

Read more ...